Article
Case report: Two sisters with a germline CHEK2 variant and distinct endocrine neoplasias
7 Nov 2022
Abstract excerpt
Genetic testing has become the standard of care for many disease states. As a result, physicians treating patients who have tumors often rely on germline genetic testing results for making clinical decisions. Cases of two sisters carrying a germline CHEK2 variant are highlighted whereby possible other genetic drivers were discovered on tumor analysis . CHEK2 (also referred to as CHK2) loss of function has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
